These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 1744086)
21. Mitochondrial beta-oxidation of 2-methyl fatty acids in rat liver. Mao LF; Chu C; Luo MJ; Simon A; Abbas AS; Schulz H Arch Biochem Biophys; 1995 Aug; 321(1):221-8. PubMed ID: 7639525 [TBL] [Abstract][Full Text] [Related]
22. Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases, and electron-transferring flavoprotein in cultured skin fibroblasts. Rhead W; Mantagos S; Tanaka K Pediatr Res; 1980 Dec; 14(12):1339-42. PubMed ID: 7208150 [TBL] [Abstract][Full Text] [Related]
24. The effect of respiratory chain impairment of beta-oxidation in rat heart mitochondria. Eaton S; Pourfarzam M; Bartlett K Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):633-40. PubMed ID: 8912705 [TBL] [Abstract][Full Text] [Related]
25. Intermediates of myocardial mitochondrial beta-oxidation: possible channelling of NADH and of CoA esters. Eaton S; Bartlett K; Pourfarzam M Biochim Biophys Acta; 1999 Mar; 1437(3):402-8. PubMed ID: 10101273 [TBL] [Abstract][Full Text] [Related]
26. Investigation of beta-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Nada MA; Chace DH; Sprecher H; Roe CR Biochem Mol Med; 1995 Feb; 54(1):59-66. PubMed ID: 7551818 [TBL] [Abstract][Full Text] [Related]
27. Energy-linked regulation of mitochondrial fatty acid oxidation in the isolated perfused rat heart. Latipää PM J Mol Cell Cardiol; 1989 Aug; 21(8):765-71. PubMed ID: 2778813 [TBL] [Abstract][Full Text] [Related]
28. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. Tyni T; Pourfarzam M; Turnbull DM Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849 [TBL] [Abstract][Full Text] [Related]
29. Multiple acyl-coenzyme A dehydrogenation disorder responsive to riboflavin: substrate oxidation, flavin metabolism, and flavoenzyme activities in fibroblasts. Rhead W; Roettger V; Marshall T; Amendt B Pediatr Res; 1993 Feb; 33(2):129-35. PubMed ID: 8433888 [TBL] [Abstract][Full Text] [Related]
30. Intermediates of peroxisomal beta-oxidation. A study of the fatty acyl-CoA esters which accumulate during peroxisomal beta-oxidation of [U-14C]hexadecanoate. Bartlett K; Hovik R; Eaton S; Watmough NJ; Osmundsen H Biochem J; 1990 Aug; 270(1):175-80. PubMed ID: 2396977 [TBL] [Abstract][Full Text] [Related]
31. Enzymatic assay for 3-hydroxyacyl-CoA and 2-trans-enoyl-CoA intermediates of beta-oxidation. Latipää PM; Hassinen IE; Hiltunen JK Anal Biochem; 1988 May; 171(1):67-72. PubMed ID: 3407922 [TBL] [Abstract][Full Text] [Related]
32. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria. Jakobs BS; Wanders RJ Biochem Biophys Res Commun; 1995 Aug; 213(3):1035-41. PubMed ID: 7654220 [TBL] [Abstract][Full Text] [Related]
33. ETF-QO Mutants Uncoupled Fatty Acid β-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology. Chokchaiwong S; Kuo YT; Hsu SP; Hsu YC; Lin SH; Zhong WB; Lin YF; Kao SH Cells; 2019 Jan; 8(2):. PubMed ID: 30709034 [TBL] [Abstract][Full Text] [Related]
35. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified. Jones PM; Burlina AB; Bennett MJ J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435 [TBL] [Abstract][Full Text] [Related]
36. The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts. Amendt BA; Rhead WJ J Clin Invest; 1986 Jul; 78(1):205-13. PubMed ID: 3722376 [TBL] [Abstract][Full Text] [Related]
37. Energetics of beta-oxidation. Reduction potentials of general fatty acyl-CoA dehydrogenase, electron transfer flavoprotein, and fatty acyl-CoA substrates. Gustafson WG; Feinberg BA; McFarland JT J Biol Chem; 1986 Jun; 261(17):7733-41. PubMed ID: 3711105 [TBL] [Abstract][Full Text] [Related]
38. Renal handling of carnitine in secondary carnitine deficiency disorders. Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025 [TBL] [Abstract][Full Text] [Related]
39. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Gregersen N Scand J Clin Lab Invest Suppl; 1985; 174():1-60. PubMed ID: 3892650 [TBL] [Abstract][Full Text] [Related]
40. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]